Mass. biotech companies still raising venture capital

07/7/2008 | Boston Globe (tiered subscription model), The

Biotech companies in Massachusetts continue to gain investments amid a declining stock market and dwindling initial public offerings. Agios Pharmaceuticals, a Boston-based firm working on drugs designed to starve cancerous cells, has secured $33 million in venture capital. Concert Pharmaceuticals and Constellation Pharmaceuticals also each have raised more than $30 million this year.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA